Changes in plasma atrial natriuretic peptide — immunoreactivity in patients undergoing coronary artery bypass graft placements
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Regulatory Peptides
- Vol. 17 (3) , 151-157
- https://doi.org/10.1016/0167-0115(87)90024-3
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Increased plasma levels of atrial natriuretic peptide in patients with congestive heart failureEuropean Heart Journal, 1986
- PLASMA ADENOSINE LEVELS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS FOR CORONARY ARTERY BYPASS GRAFTINGAnesthesiology, 1985
- PLASMA ATRIAL NATRIURETIC PEPTIDE IN CARDIAC DISEASE AND DURING INFUSION IN HEALTHY VOLUNTEERSThe Lancet, 1985
- The Heart and the Atrial Natriuretic Factor*Endocrine Reviews, 1985
- Measurement of adenosine, inosine, and hypoxanthine in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.Hypertension, 1984
- Cardiac Atria of BIO 14.6 Hamsters Are Deficient in Natriuretic FactorScience, 1984
- The amino acid sequence of an atrial peptide with potent diuretic and natriuretic propertiesBiochemical and Biophysical Research Communications, 1983
- Bioactive Cardiac Substances: Potent Vasorelaxant Activity in Mammalian AtriaScience, 1983
- Atrial reflexes and renal functionThe American Journal of Cardiology, 1979